InvestorsObserver
×
News Home

Is Epizyme Inc (EPZM) a Winner or a Loser in the Biotechnology Industry

Monday, January 27, 2020 09:59 AM | InvestorsObserver Analysts

Mentioned in this article

Is Epizyme Inc (EPZM) a Winner or a Loser in the Biotechnology Industry

The 45 rating InvestorsObserver gives to Epizyme Inc (EPZM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 44 percent of stocks in the Biotechnology industry, EPZM’s 45 overall rating means the stock scores better than 45 percent of all stocks.

Click Here to get the full Stock Score Report on Epizyme Inc (EPZM) Stock.

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 45 means the stock is more attractive than 45 percent of stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Epizyme Inc Stock Today?

Epizyme Inc (EPZM) stock is trading at $21.54 as of 9:57 AM on Monday, Jan 27, a drop of -$0.86, or -3.86% from the previous closing price of $22.40. The stock has traded between $20.26 and $22.40 so far today. Volume today is less active than usual. So far 290,842 shares have traded compared to average volume of 1,401,997 shares.

To see the top 5 stocks in Biotechnology click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App